Fresolimumab (Anti-TGFb1)

Fresolimumab (Anti-TGFb1) is a pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) beta 1, 2, and 3 with potential antineoplastic activity. MW : 145.5 KD.
Supplier Selleck Chemicals
Product # A2336
Sku # A2336-1mg
Pricing 1mg, $770.00
Feedback